Finzati - Logo
RZLT logo

Rezolute, Inc.

RZLT • Biotechnology
$4.58
▲ +0.04 (+0.88%)
Current price
Earnings
BALANCED PROFILENeutralConfidence: 0%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$409.24M
Growth
—
Cash Flow
—
Trend
Limited data
Evidence
Limited historical data
Last earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.58
Change0.88%
Market Cap$409.24M
52W Range1.07 - 11.46
Beta0.65
Target$8.67
Target Upside89.30%
Target Median$6.00
Target Range6.00 - 14.00
Volume2.08M
Avg Volume2.17M
EPS Surprise-0.02

Investment DNA

How strong this company looks for long-term investors

50
out of 100
Business Quality
Margins, moat, returns
50/100
Financial Strength
Debt, cash, stability
50/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Limited historical data

Analyst view

Analyst sentiment and price target

RZLT
Analyst sentiment
Based on 12 analyst votes · 2026-09-05
100/100
Bullish
Bullish
12
Hold
0
Bearish
0
Price Target
2026-06-06
Low
$2.00
Mean
$6.60
Median
$6.00
High
$14.00

Company Overview

IPO: 1/14/2013
Industry: Biotechnology
P/B i: -
Debt / Equity i: -
Operating Margin: -
Net Margin: -
ROE i: -
ROIC: -

Financial Health

Score0 / 20
Debt / Equity: —
Current Ratio: —
Quick Ratio: —
Status: —

Insider Transactions

Recent executive and insider activity

Evans Daron
Transaction: 03/30/2026
BUY
Change
+10,000
Price
$2.85
Filing
03/31/2026
Type
BUY
Elam Nevan C
Transaction: 03/02/2026
SELL
Change
-27,618
Price
$2.99
Filing
03/04/2026
Type
SELL
Evans Daron
Transaction: 03/02/2026
SELL
Change
-11,438
Price
$2.99
Filing
03/04/2026
Type
SELL